Calcium (Ca2+) fluxes at mitochondria-ER contact sites (MERCS) are a new target of senolysis in therapy-induced senescence (TIS)

  • Andrea Puebla-Huerta
  • , Hernán Huerta
  • , Camila Quezada-Gutierez
  • , Pablo Morgado-Cáceres
  • , César Casanova-Canelo
  • , Sandra A. Niño
  • , Sergio Linsambarth
  • , Osman Diaz Rivera
  • , José Alberto López-Domínguez
  • , SANDRA RODRIGUEZ-LOPEZ
  • , José A. González-Reyes
  • , Galdo Bustos
  • , Eduardo Silva-Pavez
  • , Alenka Lovy
  • , Gabriel Quiroz
  • , Catalina González-Seguel
  • , Edison Salas-Huenuleo
  • , Marcelo J. Kogan
  • , Jordi Molgó
  • , Armen Zakarian
  • José Manuel Villalba Montoro, Christian Gonzalez-Billault, Tito Cali, Ulises Ahumada-Castro*, Cesar Cardenas*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Therapy-induced senescence (TIS) alters calcium (Ca²⁺) flux and Mitochondria-ER Contact Sites (MERCS), revealing critical vulnerabilities in senescent cells. In this study, TIS was induced using Doxorubicin and Etoposide, resulting in an increased MERCS contact surface but a significant reduction in ER-mitochondria Ca²⁺ flux. Mechanistically, TIS cells exhibit decreased expression of IP3R isoforms and reduced interaction between type 1 IP3R and VDAC1, impairing Ca²⁺ transfer. This flux is crucial for maintaining the viability of senescent cells, highlighting its potential as a therapeutic target. Inhibition of ER-mitochondria Ca²⁺ flux demonstrates senolytic effects both in vitro and in vivo, offering a novel strategy for targeting senescent cells.

Original languageEnglish
Article number11
Journalnpj Aging
Volume11
Issue number1
StatePublished - 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

Fingerprint

Dive into the research topics of 'Calcium (Ca2+) fluxes at mitochondria-ER contact sites (MERCS) are a new target of senolysis in therapy-induced senescence (TIS)'. Together they form a unique fingerprint.

Cite this